| Parabolic Drugs has reported a sales turnover of Rs 251.65 crore and a net loss of Rs 25.25 crore for the quarter ended Sep '12. | | For the quarter ended Sep 2011 the sales turnover was Rs 198.59 crore and net profit was Rs 14.38 crore. |
|
| | Quarterly Results of Parabolic Drugs | -------- in Rs. Cr. -------- |
|
| Sep '11 | | | Jun '12 | Sep '12 | | Sales Turnover | 198.59 | | | 307.32 | 251.65 | | Other Income | -- | | | -- | -- | | Total Income | 198.59 | | | 307.32 | 251.65 | | Total Expenses | 156.02 | | | 263.95 | 248.45 | | Operating Profit | 42.57 | | | 43.37 | 3.20 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 42.57 | | | 43.37 | 3.20 | | Interest | 15.90 | | | 17.82 | 17.10 | | PBDT | 26.67 | | | 25.55 | -13.90 | | Depreciation | 7.76 | | | 12.09 | 13.98 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 18.91 | | | 13.46 | -27.88 | | Tax | 4.53 | | | 3.70 | -2.63 | | Net Profit | 14.38 | | | 9.76 | -25.25 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 2.32 | | | 1.58 | -- | | Book Value | -- | | | -- | -- | | Equity | 61.89 | | | 61.89 | 61.89 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
